SCHEMBL6565951

SCHEMBL6565951

O=C(Nc1cc(-c2ccccc2)[nH]n1)c1ccccc1Cl

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALPL P05186 1/20 0.76
ALPI P09923 1/20 0.76
NPC1 O15118 5/20 0.72
RAB9A P51151 5/20 0.72
MAPT P10636 1/20 0.70
CCNA2 P20248 1/20 0.62
CDK2 P24941 1/20 0.62
CCNA1 P78396 1/20 0.62
SMN1; SMN2 Q16637 2/20 0.59
NR1I2 O75469 1/20 0.59
AHR P35869 1/20 0.59
NPY5R Q15761 4/20 0.57
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
LMNA P02545 1/20 0.56
PKM P14618 1/20 0.56
MAPK1 P28482 1/20 0.56
PDE10A Q9Y233 1/20 0.53
SMO Q99835 2/20 0.52
CYP1A2 P05177 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4264906 0.85 ALPL (0.78) ALPLALPINPC1RAB9AMAPT
SCHEMBL6564725 0.84 RAB9A (1.00) ALPLALPINPC1RAB9AMAPT
SCHEMBL7130733 0.82 RORC (0.62) ALPLALPINPC1RAB9AMAPT
SCHEMBL6566353 0.82 NPC1 (1.00) ALPLALPINPC1RAB9AMAPT
SCHEMBL6562826 0.81 NPC1 (1.00) ALPLALPINPC1RAB9AMAPT
SCHEMBL1663611 0.79 NPC1 (0.89) ALPLALPINPC1RAB9AMAPT
SCHEMBL330223 0.77 ALPL (0.65) ALPLALPINPC1RAB9AMAPT
SCHEMBL5786202 0.76 SMO (0.49) ALPLALPINPC1RAB9AMAPT
SCHEMBL5867919 0.76 CCNA2 (1.00) CCNA2CDK2CCNA1
SCHEMBL18360452 0.76 ALPL (0.54) ALPLALPINPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0788358-B1 USE OF PYRAZOLE COMPOUNDS FOR THE TREATMENT OF GLOMERULONEPHRITIS, CANCER, ATHEROSCLEROSIS OR RESTENOSIS MILLENNIUM PHARM INC (US) 2004-03-31 EP disclosed
US-5916908-A Pharmaceutical pyrazole compositions useful as inhibitors of protein kinases COR THERAPEUTICS, INC. (US) 1999-06-29 US disclosed
EP-0788358-A2 PHARMACEUTICAL PYRAZOLE COMPOSITIONS USEFUL AS INHIBITORS OF PROTEIN KINASES COR THERAPEUTICS, INC. (US) 1997-08-13 EP disclosed
WO-1996014843-A2 PHARMACEUTICAL PYRAZOLE COMPOSITIONS USEFUL AS INHIBITORS OF PROTEIN KINASES COR THERAPEUTICS, INC. (US) 1996-05-23 WO disclosed